RESEARCHseroprevalence in domestic livestock in Saudi Arabia, 2010 to2013. Euro Surveill. 2013;18:20659.7. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A,Bagato O, et al. Seroepidemiology for MERS coronavirus usingmicroneutralisation and pseudoparticle virus neutralization assaysreveal a high prevalence of antibody in dromedary camels in Egypt,June 2013. Euro Surveill. 2013;18:20574.8. Reusken CB, Ababneh M, Raj VS, Meyer B, Eljarah A,Abutarbush S, et al. Middle East respiratory syndrome coronavirus(MERS-CoV) serology in major livestock species in an affected regionin Jordan, June to September 2013. Euro Surveill. 2013;18:20662.9. Reusken CB, Farag EA, Jonges M, Godeke GJ, El-Sayed AM,Pas SD, et al. Middle East respiratory syndrome coronavirus(MERS-CoV) RNA and neutralising antibodies in milk collectedaccording to local customs from dromedary camels, Qatar, April2014. Euro Surveill. 2014;19:20829.10. Reusken CB, Messadi L, Feyisa A, Ularamu H, Godeke GJ,Danmarwa A, et al. Geographic distribution of MERS coronavirusamong dromedary camels, Africa. Emerg Infect Dis.2014;20:1370–4. http://dx.doi.org/10.3201/eid2008.14059011. Meyer B, Müller MA, Corman VM, Reusken CBEM, Ritz D,Godeke GD, et al. Antibodies against MERS coronavirus in dromedarycamels, United Arab Emirates, 2003 and 2013. Emerg InfectDis. 2014;20:552–9. http://dx.doi.org/10.3201/eid2004.13174612. Hemida MG, Perera RA, Al Jassim RA, Kayali G, Siu LY,Wang P, et al. Seroepidemiology of Middle East respiratorysyndrome (MERS) coronavirus in Saudi Arabia (1993) andAustralia (2014) and characterization of assay specificity.Euro Surveill. 2014;12;19:20828.13. Haagmans BL, Al Dhahiry SH, Reusken CB, Raj VS, Galiano M,Myers R, et al. Middle East respiratory syndrome coronavirus indromedary camels: an outbreak investigation. Lancet Infect Dis.2014;14:140–5. http://dx.doi.org/10.1016/S1473-3099(13)70690-X14. Nowotny N, Kolodziejek J. Middle East respiratory syndromecoronavirus (MERS-CoV) in dromedary camels, Oman, 2013.Euro Surveill. 2014;19:20781.15. Memish ZA, Cotten M, Meyer B, Watson SJ, Alsahafi AJ,Al Rabeeah AA, et al. Human infection with MERS coronavirusafter exposure to infected camels, Saudi Arabia, 2013. Emerg InfectDis. 2014;20:1012–5. http://dx.doi.org/10.3201/eid2006.14040216. Hemida MG, Chu DKW, Poon LL, Perera RA, Alhammadi MA,Ng H-Y, et al. MERS coronavirus in dromedary camel herd, SaudiArabia. Emerg Infect Dis. 2014;20:1231–4. http://dx.doi.org/10.3201/eid2007.14057117. Chu DKW, Poon LL, Gomaa MM, Shehata MM, Perera RAPM,Zeid DA, et al. MERS coronaviruses in dromedary camels, Egypt.Emerg Infect Dis. 2014;20:1049–53. http://dx.doi.org/10.3201/eid2006.14029918. Vijgen L, Moës E, Keyaerts E, Li S, Van Ranst M. A pancoronavirusRT-PCR assay for detection of all known coronaviruses.Methods Mol Biol. 2008;454:3–12. http://dx.doi.org/10.1007/978-1-59745-181-9_119. Lu X, Whitaker B, Sakthivel S, Kamili S, Rose LE, Lowe L, et al.Real-time reverse transcription polymerase chain reaction assaypanel for Middle East respiratory syndrome coronavirus. J ClinMicrobiol. 2014;52:67–75. http://dx.doi.org/10.1128/JCM.02533-1320. Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O,Eschbach-Bludau M, et al. Detection of a novel human coronavirusby real-time reverse-transcription polymerase chain reaction.Euro Surveill. 2012;17:20285.21. Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P, et al. Structureof MERS-CoV spike receptor-binding domain complexed withhuman receptor DPP4. Cell Res. 2013;23:986–93.http://dx.doi.org/10.1038/cr.2013.9222. Yusof MF, Eltahir YM, Serhan WS, Hashem FM, Elsayed EA,Marzoug BA, et al. Prevalence of Middle East respiratorysyndrome coronavirus (MERS-CoV) in dromedary camels in AbuDhabi Emirate, United Arab Emirates [cited 2015 Feb 25]. VirusGenes. 2015:Feb 5 [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/2565301623. Adney DR, van Doremalen N, Brown VR, Bushmaker T, Scott D,de Wit E, et al. Replication and shedding of MERS-CoV in upperrespiratory tract of inoculated dromedary camels. Emerg Infect Dis.2014;20:1999–2005. http://dx.doi.org/10.3201/eid2012.14128024. Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N,Lemaire X, et al.; MERS-CoV study group. Clinical features andviral diagnosis of two cases of infection with Middle Eastrespiratory syndrome coronavirus: a report of nosocomialtransmission. Lancet. 2013;381:2265–72. http://dx.doi.org/10.1016/S0140-6736(13)60982-425. Bermingham A, Chand MA, Brown CS, Aarons E, Tong C,Langrish C, et al. Severe respiratory illness caused by a novelcoronavirus, in a patient transferred to the United Kingdom fromthe Middle East, September 2012. Euro Surveill. 2012;17:20290.26. van Doremalen N, Bushmaker T, Munster VJ. Stability of MiddleEast respiratory syndrome coronavirus (MERS-CoV) under differentenvironmental conditions. Euro Surveill. 2013;18:20590.27. Chan KH, Peiris JS, Lam SY, Poon LL, Yuen KY, Seto WH. The effects of temperature and relative humidity on the viability ofthe SARS coronavirus. Adv Virol. 2011;2011:734690.http://dx.doi.org/10.1155/2011/73469028. Bakir TM, Halawani M, Ramia S. Viral aetiology andepidemiology of acute respiratory infections in hospitalized Saudichildren. J Trop Pediatr. 1998;44:100–3. http://dx.doi.org/10.1093/tropej/44.2.10029. al-Hajjar S, Akhter J, al Jumaah S, Hussain Qadri SM.Respiratory viruses in children attending a major referral centre inSaudi Arabia. Ann Trop Paediatr. 1998;18:87–92.30. Bukhari EE, Elhazmi MM. Viral agents causing acute lowerrespiratory tract infections in hospitalized children at a tertiary carecenter in Saudi Arabia. Saudi Med J. 2013;34:1151–5.31. Azhar EI, Hashem AM, El-Kafrawy SA, Sohrab SS, AburizaizaAS, Farraj SA, et al. Evidence for camel-to-human transmission ofMERS coronavirus. N Engl J Med. 2014;370:2499–505.http://dx.doi.org/10.1056/NEJMoa140150532. Aburizaiza AS, Mattes FM, Azhar EI, Hassan AM, Memish ZA,Muth D, et al. Investigation of anti–Middle East respiratorysyndrome antibodies in blood donors and slaughterhouse workersin Jeddah and Makkah, Saudi Arabia, fall 2012. J Infect Dis.2014;209:243–6. http://dx.doi.org/10.1093/infdis/jit58933. Memish ZA, Alsahly A, Masri MA, Heil GL, Anderson BD, Peiris M,et al. Sparse evidence of MERS-CoV infection among animal workersliving in southern Saudi Arabia during 2012. Influenza OtherRespir Viruses. 2014 Dec 3. http://dx.doi.org/10.1111/irv.1228734. Hemida MG, Al-Naeem A, Perera RA, Chin AW, Poon LL, Peiris M.Lack of Middle East respiratory syndrome coronavirus transmissionfrom infected camels. Emerg Infect Dis. 2015; 21:699–701.http://dx.doi.org/10.3201/eid2104.14194935. Alghamdi IG, Hussain II, Almalki SS, Alghamdi MS,Alghamdi MM, El-Sheemy MA. The pattern of Middle East respiratorysyndrome coronavirus in Saudi Arabia: a descriptive epidemiologicalanalysis of data from the Saudi ministry of Health. Int J GenMed. 2014;7:417–23. http://dx.doi.org/10.2147/IJGM.S6706136. World Health Organization. Middle East respiratory syndromecoronavirus (MERS-CoV): summary of current situation, literatureupdate and risk assessment [cited 2015 Feb 5]. http://www.who.int/csr/disease/coronavirus_infections/mers-5-february-2015.<strong>pdf</strong>?ua=1Address for correspondence: Dean D. Erdman, Centers for DiseaseControl and Prevention, 1600 Clifton Rd NE, Mailstop G04, Atlanta, GA30329-4027, USA; email: dde1@cdc.gov1158 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 21, No. 7, July 2015
Assessment of ArbovirusSurveillance 13 Years afterIntroduction of West Nile Virus,United States 1James L. Hadler, Dhara Patel, Roger S. Nasci, Lyle R. Petersen, James M. Hughes,Kristy Bradley, Paul Etkind, Lilly Kan, Jeffrey EngelBefore 1999, the United States had no appropriated fundingfor arboviral surveillance, and many states conductedno such surveillance. After emergence of West Nile virus(WNV), federal funding was distributed to state and selectedlocal health departments to build WNV surveillancesystems. The Council of State and Territorial Epidemiologistsconducted assessments of surveillance capacity ofresulting systems in 2004 and in 2012; the assessment in2012 was conducted after a 61% decrease in federal funding.In 2004, nearly all states and assessed local healthdepartments had well-developed animal, mosquito, and humansurveillance systems to monitor WNV activity and anticipateoutbreaks. In 2012, many health departments haddecreased mosquito surveillance and laboratory testing capacityand had no systematic disease-based surveillancefor other arboviruses. Arboviral surveillance in many statesmight no longer be sufficient to rapidly detect and provideinformation needed to fully respond to WNV outbreaks andother arboviral threats (e.g., dengue, chikungunya).Before 1999, there was no appropriated funding in theUnited States for arboviral surveillance, and manystates had no arboviral surveillance systems (2). After theemergence of West Nile virus (WNV) in New York, NewYork, in 1999 (3), Congress appropriated annual fundingto support WNV surveillance activities in affected statesand large cities; funds were awarded to these areas throughepidemiology and laboratory capacity (ELC) cooperativeagreements from the Centers for Disease Control and Prevention.CDC collaborated with state, local health, andAuthor affiliations: Yale University School of Public Health, NewHaven, Connecticut, USA (J.L. Hadler); Council of State andTerritorial Epidemiologists, Atlanta, Georgia, USA (D. Patel,J. Engel); Centers for Disease Control and Prevention,Fort Collins, Colorado, USA (R.S. Nasci, L.R. Petersen); EmoryUniversity School of Medicine, Atlanta (J.M. Hughes); OklahomaState Department of Health, Oklahoma City, Oklahoma, USA(K. Bradley); National Association of County and City HealthOfficials, Washington, DC, USA (P. Etkind, L. Kan)DOI: http://dx.doi.org/10.3201/eid2107.140858academic partners to develop WNV detection, monitoring,and prevention guidance (4,5). By 2004, WNV had spreadacross the continental United States (6), and transmissionto humans had been documented by multiple routes, includingblood transfusions and organ transplantation (7–10). That year, CDC distributed nearly $24 million to allstates and 6 large city/county health departments for WNVsurveillance and prevention.In 2000, CDC established ArboNET, a comprehensivenational surveillance data capture platform to monitorWNV patterns. In 2003, CDC expanded ArboNET toinclude other arboviral diseases. ArboNET relies on a distributedsurveillance system, whereby ELC-supported stateand local health departments report data weekly on detectionof arboviruses in humans, animals, and mosquitoes.CDC posts all data on the Internet with weekly updates(11). In 2004, the Council of State and Territorial Epidemiologists(CSTE) conducted a WNV surveillance capacityassessment and found that WNV surveillance programswere in place and well developed in jurisdictions receivingWNV surveillance funding (12). CSTE attributed the successof capacity development primarily to availability offederal funds and technical guidance from CDC.Annual funding for WNV and other arbovirus surveillancedistributed through the ELC cooperative agreementshas steadily decreased since 2006 to 39% of its2004 zenith, reaching lows of $9.3 million in 2012 and in2013 (R.S. Nasci, unpub. data). Concomitantly in 2012,the nation experienced the highest incidence of confirmedWNV neuroinvasive disease since 2003 and the highestnumber of confirmed deaths (286) for any year thus far(13). In addition to the continued challenge of WNV tofinancially stressed arbovirus surveillance systems, thereis the growing threat of other arboviral diseases, such asdengue (14), chikungunya (15–17), and Powassan virusencephalitis (18).In August 2013, CSTE conducted another assessmentof state and selected local health departments (LHDs) to1A shorter <strong>version</strong> of this report has been published previously (1).Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 21, No. 7, July 2015 1159
- Page 3 and 4:
July 2015SynopsisOn the CoverMarian
- Page 5 and 6:
1240 Gastroenteritis OutbreaksCause
- Page 7 and 8:
SYNOPSISDisseminated Infections wit
- Page 9 and 10:
Disseminated Infections with Talaro
- Page 11 and 12:
Disseminated Infections with Talaro
- Page 13 and 14: Macacine Herpesvirus 1 inLong-Taile
- Page 15 and 16: Macacine Herpesvirus 1 in Macaques,
- Page 17 and 18: Macacine Herpesvirus 1 in Macaques,
- Page 19: Macacine Herpesvirus 1 in Macaques,
- Page 23: Malaria among Young Infants, Africa
- Page 26 and 27: RESEARCHFigure 3. Dynamics of 19-kD
- Page 28 and 29: Transdermal Diagnosis of MalariaUsi
- Page 30 and 31: RESEARCHFigure 2. A) Acoustic trace
- Page 32 and 33: RESEARCHof malaria-infected mosquit
- Page 34 and 35: Lack of Transmission amongClose Con
- Page 36 and 37: RESEARCH(IFA) and microneutralizati
- Page 38 and 39: RESEARCHoropharyngeal, and serum sa
- Page 40 and 41: RESEARCH6. Assiri A, McGeer A, Perl
- Page 42 and 43: RESEARCHadvanced genomic sequencing
- Page 44 and 45: RESEARCHTable 2. Next-generation se
- Page 46 and 47: RESEARCHTable 3. Mutation analysis
- Page 48 and 49: RESEARCHReferences1. Baize S, Panne
- Page 50 and 51: Parechovirus Genotype 3 Outbreakamo
- Page 52 and 53: RESEARCHFigure 1. Venn diagramshowi
- Page 54 and 55: RESEARCHTable 2. HPeV testing of sp
- Page 56 and 57: RESEARCHFigure 5. Distribution of h
- Page 58 and 59: RESEARCHReferences1. Selvarangan R,
- Page 60 and 61: RESEARCHthe left lobe was sampled b
- Page 62 and 63: RESEARCHTable 2. Middle East respir
- Page 66 and 67: RESEARCHmeasure their current surve
- Page 68 and 69: RESEARCHTable 2. States with labora
- Page 70 and 71: RESEARCHFigure 2. Comparison of sur
- Page 72 and 73: RESEARCH9. Centers for Disease Cont
- Page 74 and 75: RESEARCHthe analyses. Cases in pers
- Page 76 and 77: RESEARCHTable 3. Sampling results (
- Page 78 and 79: RESEARCHpresence of Legionella spp.
- Page 80 and 81: Seroprevalence for Hepatitis Eand O
- Page 82 and 83: RESEARCHTable 1. Description of stu
- Page 84 and 85: RESEARCHTable 3. Crude and adjusted
- Page 86 and 87: RESEARCHrates by gender or HIV stat
- Page 88 and 89: RESEARCH25. Taha TE, Kumwenda N, Ka
- Page 90 and 91: POLICY REVIEWDutch Consensus Guidel
- Page 92 and 93: POLICY REVIEWTable 3. Comparison of
- Page 94 and 95: POLICY REVIEW6. Botelho-Nevers E, F
- Page 96 and 97: DISPATCHESFigure 1. Phylogenetic tr
- Page 98 and 99: DISPATCHESSevere Pediatric Adenovir
- Page 100 and 101: DISPATCHESTable 1. Demographics and
- Page 102 and 103: DISPATCHES13. Kim YJ, Hong JY, Lee
- Page 104 and 105: DISPATCHESTable. Alignment of resid
- Page 106 and 107: DISPATCHESFigure 2. Interaction of
- Page 108 and 109: DISPATCHESSchmallenberg Virus Recur
- Page 110 and 111: DISPATCHESFigure 2. Detection of Sc
- Page 112 and 113: DISPATCHESFigure 1. Histopathologic
- Page 114:
DISPATCHESFigure 2. Detection of fo
- Page 117 and 118:
Influenza Virus Strains in the Amer
- Page 119 and 120:
Novel Arenavirus Isolates from Nama
- Page 121 and 122:
Novel Arenaviruses, Southern Africa
- Page 123 and 124:
Readability of Ebola Informationon
- Page 125 and 126:
Readability of Ebola Information on
- Page 127 and 128:
Patients under investigation for ME
- Page 129 and 130:
Patients under investigation for ME
- Page 131 and 132:
Wildlife Reservoir for Hepatitis E
- Page 133 and 134:
Asymptomatic Malaria and Other Infe
- Page 135 and 136:
Asymptomatic Malaria in Children fr
- Page 137 and 138:
Bufavirus in Wild Shrews and Nonhum
- Page 139 and 140:
Bufavirus in Wild Shrews and Nonhum
- Page 141 and 142:
Range Expansion for Rat Lungworm in
- Page 143 and 144:
Slow Clearance of Plasmodium falcip
- Page 145 and 146:
Slow Clearance of Plasmodium falcip
- Page 147 and 148:
Gastroenteritis Caused by Norovirus
- Page 149 and 150:
Ebola Virus Stability on Surfaces a
- Page 151 and 152:
Ebola Virus Stability on Surfaces a
- Page 153 and 154:
Outbreak of Ciprofloxacin-Resistant
- Page 155 and 156:
Outbreak of S. sonnei, South KoreaT
- Page 157 and 158:
Rapidly Expanding Range of Highly P
- Page 159 and 160:
Cluster of Ebola Virus Disease, Bon
- Page 161 and 162:
Cluster of Ebola Virus Disease, Lib
- Page 163 and 164:
ANOTHER DIMENSIONThe Past Is Never
- Page 165 and 166:
Measles Epidemic, Boston, Massachus
- Page 167 and 168:
LETTERSInfluenza A(H5N6)Virus Reass
- Page 169 and 170:
LETTERSsystem (8 kb-span paired-end
- Page 171 and 172:
LETTERS3. Van Hong N, Amambua-Ngwa
- Page 173 and 174:
LETTERSTable. Prevalence of Bartone
- Page 175 and 176:
LETTERSavian influenza A(H5N1) viru
- Page 177 and 178:
LETTERSprovinces and a total of 200
- Page 179 and 180:
LETTERS7. Manian FA. Bloodstream in
- Page 181 and 182:
LETTERSforward projections. N Engl
- Page 183 and 184:
LETTERS3. Guindon S, Gascuel OA. Si
- Page 185 and 186:
BOOKS AND MEDIAin the port cities o
- Page 187 and 188:
ABOUT THE COVERNorth was not intere
- Page 189 and 190:
Earning CME CreditTo obtain credit,
- Page 191:
Emerging Infectious Diseases is a p